Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection
María Pernas(Instituto de Salud Carlos III), Ezequiel Ruíz-Mateos(Apple (Israel)), Mayte Coiras(Instituto de Salud Carlos III), Isabel Olivares(Instituto de Salud Carlos III), Manuel Leal(Apple (Israel)), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Josep Gómez(Institut de Recerca Biomèdica Catalunya Sud), Júlia G. Prado(Universitat Autònoma de Barcelona), Norma Rallón, José M. Benito(Hospital Universitario Rey Juan Carlos), Concha Casado(Instituto de Salud Carlos III), José Alcamı́(Apple (Israel)), Montserrat Plana(Fundació Clínic per a la Recerca Biomèdica), Cecilio López‐Galíndez(Apple (Israel)), Agathe León(Hospital Clínic de Barcelona), Marta Dapena, Felipe García(Apple (Israel)), Laura Tarancón‐Díez(Instituto de Biomedicina de Sevilla), José Antonio Iribarren(Biogipuzkoa Health Research Institute), Carmen Rodríguez(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Beatriz Domínguez-Molina(Instituto de Biomedicina de Sevilla), Onofre Martínez‐Madrid(Santa Lucía University General Hospital), Esther Rodríguez‐Gallego(Institut de Recerca Biomèdica Catalunya Sud)
Cited by 78
Related Papers
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis
|The Lancet Neurology|2018|645
Ultraviolet vision in lizards
|Nature|1993|257
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection
|AIDS|2004|115
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
|Journal of Clinical Investigation|2021|110